Philip Liang - Jun 6, 2022 Form 4 Insider Report for Vicarious Surgical Inc. (RBOT)

Role
Director
Signature
/s/ June Morris, Attorney-in-Fact
Stock symbol
RBOT
Transactions as of
Jun 6, 2022
Transactions value $
-$91,290
Form type
4
Date filed
6/8/2022, 04:03 PM
Previous filing
Jun 3, 2022
Next filing
Jul 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RBOT Class A Common Stock Sale -$91.3K -20K -1.56% $4.56 1.26M Jun 6, 2022 Direct F1
holding RBOT Class A Common Stock 43.9K Jun 6, 2022 By Chelvey International Limited F2
holding RBOT Class A Common Stock 330K Jun 6, 2022 By E15 Fund Advisors (HK) Limited F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This figure is the weighted average sales price of multiple trades ranging from $4.515 to $4.595 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.
F2 Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.
F3 Shares held directly by E15 Fund Advisors (HK) Limited. The Reporting Person, as the managing partner of E15 Fund Advisors (HK) Limited, may be deemed to share voting and dispositive power over the shares held by E15 Fund Advisors (HK) Limited. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund Advisors (HK) Limited, except to the extent of any pecuniary interest therein.